• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    TrovaGene, Inc. (TROV)

    -NasdaqCM
    5.65 Up 0.11(1.99%) Feb 27, 4:00PM EST
    Add to Portfolio
    Prev Close:5.54
    Open:5.50
    Bid:4.56 x 1000
    Ask:N/A
    1y Target Est:8.08
    Beta:0.23
    Next Earnings Date:12-Mar-15TROV Earnings announcement
    Day's Range:5.48 - 5.73
    52wk Range:2.97 - 7.10
    Volume:224,875
    Avg Vol (3m):190,174
    Market Cap:106.80M
    P/E (ttm):N/A
    EPS (ttm):-0.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TROV

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):386.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.77
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trovagene, Inc. develops its proprietary technology for the detection and monitoring of circulating tumor DNA in both urine and blood. Its technology detects and quantitates oncogene mutations in cancer patients for improved disease management. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback